MOODY LYNN & LIEBERSON, LLC – Regeneron Pharmaceuticals, Inc. Transaction History
MOODY LYNN & LIEBERSON, LLC portfolio value:
$2.94M
portfolio value
MOODY LYNN & LIEBERSON, LLC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -44.21% | -3.38K shares | -1.58M | $688.87 | 4.27K |
| Q2 2022 | share | Decrease | -4.77% | -384 shares | -1.09M | $591.13 | 7.66K |
| Q1 2022 | share | Increase | 0.00% | 8.04K shares | 5.61M | $698.42 | 8.04K |
| Q4 2021 | share | Decrease | -100.00% | -6.46K shares | -3.91M | $642.51 | 0 |
| Q3 2021 | share | Increase | 0.00% | 6.46K shares | 3.91M | $605.18 | 6.46K |
| Q3 2020 | share | Decrease | -100.00% | -9.10K shares | -5.68M | $559.78 | 0 |
| Q2 2020 | share | Increase | +69.07% | 3.72K shares | 3.05M | $623.65 | 9.10K |
| Q1 2020 | share | Decrease | -54.90% | -6.55K shares | -1.85M | $488.29 | 5.38K |
| Q4 2019 | share | Increase | 0.00% | 11.94K shares | 4.48M | $375.48 | 11.94K |
| Q3 2017 | share | Decrease | -100.00% | -4.17K shares | -2.04M | $447.12 | 0 |
| Q2 2017 | share | Decrease | -5.95% | -264 shares | 330K | $491.14 | 4.17K |
| Q1 2017 | share | Increase | 0.00% | 4.43K shares | 1.71M | $387.51 | 4.43K |
| Q2 2016 | share | Decrease | -100.00% | -5.90K shares | -2.12M | $349.23 | 0 |
| Q1 2016 | share | Increase | +60.37% | 2.22K shares | 129K | $360.44 | 5.90K |